Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

108 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cabozantinib in Patients with Advanced Renal Cell Carcinoma Primary Refractory to First-line Immunocombinations or Tyrosine Kinase Inhibitors.
Santoni M, Massari F, Bracarda S, Grande E, Matrana MR, Rizzo M, De Giorgi U, Basso U, Aurilio G, Incorvaia L, Martignetti A, Molina-Cerrillo J, Mollica V, Rizzo A, Battelli N. Santoni M, et al. Among authors: battelli n. Eur Urol Focus. 2022 Nov;8(6):1696-1702. doi: 10.1016/j.euf.2022.02.004. Epub 2022 Feb 19. Eur Urol Focus. 2022. PMID: 35193819
Immune checkpoint inhibitors for metastatic bladder cancer.
Massari F, Di Nunno V, Cubelli M, Santoni M, Fiorentino M, Montironi R, Cheng L, Lopez-Beltran A, Battelli N, Ardizzoni A. Massari F, et al. Among authors: battelli n. Cancer Treat Rev. 2018 Mar;64:11-20. doi: 10.1016/j.ctrv.2017.12.007. Epub 2018 Jan 31. Cancer Treat Rev. 2018. PMID: 29407369 Review.
Durvalumab in Stage III Non-Small-Cell Lung Cancer.
Santoni M, Battelli N, Buti S. Santoni M, et al. Among authors: battelli n. N Engl J Med. 2018 Mar 1;378(9):869. doi: 10.1056/NEJMc1716426. N Engl J Med. 2018. PMID: 29504721 No abstract available.
Tivozanib for the treatment of renal cell carcinoma.
Santoni M, Massari F, Piva F, Carrozza F, Di Nunno V, Cimadamore A, Martignetti A, Montironi R, Battelli N. Santoni M, et al. Among authors: battelli n. Expert Opin Pharmacother. 2018 Jun;19(9):1021-1025. doi: 10.1080/14656566.2018.1480722. Epub 2018 May 31. Expert Opin Pharmacother. 2018. PMID: 29851529
Immunotherapy in renal cell carcinoma: latest evidence and clinical implications.
Santoni M, Massari F, Di Nunno V, Conti A, Cimadamore A, Scarpelli M, Montironi R, Cheng L, Battelli N, Lopez-Beltran A. Santoni M, et al. Among authors: battelli n. Drugs Context. 2018 Jun 5;7:212528. doi: 10.7573/dic.212528. eCollection 2018. Drugs Context. 2018. PMID: 29899754 Free PMC article.
Re: Gladell P. Paner, Walter M. Stadler, Donna E. Hansel, Rodolfo Montironi, Daniel W. Lin, Mahul B. Amin. Updates in the Eighth Edition of the Tumor-node-metastasis Staging Classification for Urologic Cancers. Eur Urol 2018;73:560-9: Tumour, Node, and Metastasis Staging System for Urological Malignancies: Are We Ready for the Next Step?
Di Nunno V, Santoni M, Cimadamore A, Battelli N, Massari F. Di Nunno V, et al. Among authors: battelli n. Eur Urol. 2018 Nov;74(5):e118-e119. doi: 10.1016/j.eururo.2018.06.050. Epub 2018 Jul 13. Eur Urol. 2018. PMID: 30017397 No abstract available.
108 results